TABLE 1.
Screening strategy designation | Screening strategy description | Definition of positive imaging result | After positive imaging results | After negative imaging results |
1 | Standard biopsy | N/A (no imaging) | N/A; always standard biopsy | N/A; always standard biopsy |
2 | mpMRI alone (Likert scores) | Likert 4–5 | Combined biopsy | Standard biopsy |
3 | mpMRI alone (PI-RADS scores) | PI-RADSv2 3–5 | Combined biopsy | Standard biopsy |
4 | 18F-choline PET/mpMRI (Likert scores) | Likert 5 mpMRI lesion or Likert 3–4 mpMRI lesion with 18F-choline TBR of ≥1.58* | Combined biopsy | Standard biopsy |
5 | 18F-choline PET/mpMRI (PI-RADS scores) | PI-RADS 5 mpMRI lesion or PI-RADS 3–4 mpMRI lesion with 18F-choline TBR of ≥1.58 | Combined biopsy | Standard biopsy |
6 | mpMRI alone (Likert scores) | Likert 4–5 | Combined biopsy | No biopsy |
7 | mpMRI alone (PI-RADS scores) | PI-RADS 3–5 | Combined biopsy | No biopsy |
8 | 18F-choline PET/mpMRI (Likert scores) | Likert 5 mpMRI lesion or Likert 3–4 mpMRI lesion with 18F-choline TBR of ≥1.58 | Combined biopsy | No biopsy |
9 | 18F-choline PET/mpMRI (PI-RADS scores) | PI-RADS 5 mpMRI lesion or PI-RADS 3–4 mpMRI lesion with 18F-choline TBR of ≥1.58 | Combined biopsy | No biopsy |
TBR threshold was defined in study by Piert et al. (8).
N/A = not applicable.